Copyright Reports & Markets. All rights reserved.

Global Leber Congenital Amaurosis (LCA) Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Leber Congenital Amaurosis (LCA) Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Infantile Type
      • 1.4.3 Juvenile Type
    • 1.5 Market by Application
      • 1.5.1 Global Leber Congenital Amaurosis (LCA) Market Share by Application (2019-2025)
      • 1.5.2 Hospitals
      • 1.5.3 Eye Clinics
      • 1.5.4 Medical Research Institute
      • 1.5.5 Other
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Leber Congenital Amaurosis (LCA) Market Size
    • 2.2 Leber Congenital Amaurosis (LCA) Growth Trends by Regions
      • 2.2.1 Leber Congenital Amaurosis (LCA) Market Size by Regions (2019-2025)
      • 2.2.2 Leber Congenital Amaurosis (LCA) Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Challenges
      • 2.3.4 Porter’s Five Forces Analysis

    3 Market Share by Key Players

    • 3.1 Leber Congenital Amaurosis (LCA) Market Size by by Players
      • 3.1.1 Global Leber Congenital Amaurosis (LCA) Revenue by by Players (2014-2019)
      • 3.1.2 Global Leber Congenital Amaurosis (LCA) Revenue Market Share by by Players (2014-2019)
      • 3.1.3 Global Leber Congenital Amaurosis (LCA) Market Concentration Ratio (CR5 and HHI)
    • 3.2 Leber Congenital Amaurosis (LCA) Key Players Head office and Area Served
    • 3.3 Key Players Leber Congenital Amaurosis (LCA) Product/Solution/Service
    • 3.4 Date of Enter into Leber Congenital Amaurosis (LCA) Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Leber Congenital Amaurosis (LCA) Market Size by Type (2014-2019)
    • 4.2 Global Leber Congenital Amaurosis (LCA) Market Size by Application (2014-2019)

    5 North America

    • 5.1 North America Leber Congenital Amaurosis (LCA) Market Size (2014-2019)
    • 5.2 Leber Congenital Amaurosis (LCA) Key Players in North America
    • 5.3 North America Leber Congenital Amaurosis (LCA) Market Size by Type
    • 5.4 North America Leber Congenital Amaurosis (LCA) Market Size by Application

    6 Europe

    • 6.1 Europe Leber Congenital Amaurosis (LCA) Market Size (2014-2019)
    • 6.2 Leber Congenital Amaurosis (LCA) Key Players in Europe
    • 6.3 Europe Leber Congenital Amaurosis (LCA) Market Size by Type
    • 6.4 Europe Leber Congenital Amaurosis (LCA) Market Size by Application

    7 China

    • 7.1 China Leber Congenital Amaurosis (LCA) Market Size (2014-2019)
    • 7.2 Leber Congenital Amaurosis (LCA) Key Players in China
    • 7.3 China Leber Congenital Amaurosis (LCA) Market Size by Type
    • 7.4 China Leber Congenital Amaurosis (LCA) Market Size by Application

    8 Japan

    • 8.1 Japan Leber Congenital Amaurosis (LCA) Market Size (2014-2019)
    • 8.2 Leber Congenital Amaurosis (LCA) Key Players in Japan
    • 8.3 Japan Leber Congenital Amaurosis (LCA) Market Size by Type
    • 8.4 Japan Leber Congenital Amaurosis (LCA) Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Leber Congenital Amaurosis (LCA) Market Size (2014-2019)
    • 9.2 Leber Congenital Amaurosis (LCA) Key Players in Southeast Asia
    • 9.3 Southeast Asia Leber Congenital Amaurosis (LCA) Market Size by Type
    • 9.4 Southeast Asia Leber Congenital Amaurosis (LCA) Market Size by Application

    10 India

    • 10.1 India Leber Congenital Amaurosis (LCA) Market Size (2014-2019)
    • 10.2 Leber Congenital Amaurosis (LCA) Key Players in India
    • 10.3 India Leber Congenital Amaurosis (LCA) Market Size by Type
    • 10.4 India Leber Congenital Amaurosis (LCA) Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Leber Congenital Amaurosis (LCA) Market Size (2014-2019)
    • 11.2 Leber Congenital Amaurosis (LCA) Key Players in Central & South America
    • 11.3 Central & South America Leber Congenital Amaurosis (LCA) Market Size by Type
    • 11.4 Central & South America Leber Congenital Amaurosis (LCA) Market Size by Application

    12 International Players Profiles

    • 12.1 AmpliPhi Biosciences
      • 12.1.1 AmpliPhi Biosciences Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Leber Congenital Amaurosis (LCA) Introduction
      • 12.1.4 AmpliPhi Biosciences Revenue in Leber Congenital Amaurosis (LCA) Business (2014-2019))
      • 12.1.5 AmpliPhi Biosciences Recent Development
    • 12.2 Editas Medicine
      • 12.2.1 Editas Medicine Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Leber Congenital Amaurosis (LCA) Introduction
      • 12.2.4 Editas Medicine Revenue in Leber Congenital Amaurosis (LCA) Business (2014-2019)
      • 12.2.5 Editas Medicine Recent Development
    • 12.3 Novelion Therapeutics
      • 12.3.1 Novelion Therapeutics Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Leber Congenital Amaurosis (LCA) Introduction
      • 12.3.4 Novelion Therapeutics Revenue in Leber Congenital Amaurosis (LCA) Business (2014-2019)
      • 12.3.5 Novelion Therapeutics Recent Development
    • 12.4 ProQR Therapeutics
      • 12.4.1 ProQR Therapeutics Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Leber Congenital Amaurosis (LCA) Introduction
      • 12.4.4 ProQR Therapeutics Revenue in Leber Congenital Amaurosis (LCA) Business (2014-2019)
      • 12.4.5 ProQR Therapeutics Recent Development
    • 12.5 Spark Therapeutics
      • 12.5.1 Spark Therapeutics Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Leber Congenital Amaurosis (LCA) Introduction
      • 12.5.4 Spark Therapeutics Revenue in Leber Congenital Amaurosis (LCA) Business (2014-2019)
      • 12.5.5 Spark Therapeutics Recent Development

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Product (2019-2025)
    • 13.2 Market Size Forecast by Application (2019-2025)
    • 13.3 Market Size Forecast by Regions
    • 13.4 North America
    • 13.5 Europe
    • 13.6 China
    • 13.7 Japan
    • 13.8 Southeast Asia
    • 13.9 India
    • 13.10 Central & South America

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 15.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      This report focuses on the global Leber Congenital Amaurosis (LCA) status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Leber Congenital Amaurosis (LCA) development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

      The key players covered in this study
      AmpliPhi Biosciences
      Editas Medicine
      Novelion Therapeutics
      ProQR Therapeutics
      Spark Therapeutics
      ...

      Market segment by Type, the product can be split into
      Infantile Type
      Juvenile Type

      Market segment by Application, split into
      Hospitals
      Eye Clinics
      Medical Research Institute
      Other

      Market segment by Regions/Countries, this report covers
      North America
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Leber Congenital Amaurosis (LCA) status, future forecast, growth opportunity, key market and key players.
      To present the Leber Congenital Amaurosis (LCA) development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Leber Congenital Amaurosis (LCA) are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
      Buy now